1. Home
  2. OCGN vs EVC Comparison

OCGN vs EVC Comparison

Compare OCGN & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • EVC
  • Stock Information
  • Founded
  • OCGN 2013
  • EVC 1996
  • Country
  • OCGN United States
  • EVC United States
  • Employees
  • OCGN N/A
  • EVC N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • EVC Broadcasting
  • Sector
  • OCGN Health Care
  • EVC Industrials
  • Exchange
  • OCGN Nasdaq
  • EVC Nasdaq
  • Market Cap
  • OCGN 189.6M
  • EVC 171.0M
  • IPO Year
  • OCGN N/A
  • EVC 2000
  • Fundamental
  • Price
  • OCGN $0.67
  • EVC $1.89
  • Analyst Decision
  • OCGN Strong Buy
  • EVC
  • Analyst Count
  • OCGN 3
  • EVC 0
  • Target Price
  • OCGN $6.33
  • EVC N/A
  • AVG Volume (30 Days)
  • OCGN 3.2M
  • EVC 176.9K
  • Earning Date
  • OCGN 05-09-2025
  • EVC 05-08-2025
  • Dividend Yield
  • OCGN N/A
  • EVC 10.53%
  • EPS Growth
  • OCGN N/A
  • EVC N/A
  • EPS
  • OCGN N/A
  • EVC N/A
  • Revenue
  • OCGN $4,522,000.00
  • EVC $378,623,000.00
  • Revenue This Year
  • OCGN N/A
  • EVC $64.06
  • Revenue Next Year
  • OCGN N/A
  • EVC N/A
  • P/E Ratio
  • OCGN N/A
  • EVC N/A
  • Revenue Growth
  • OCGN N/A
  • EVC N/A
  • 52 Week Low
  • OCGN $0.52
  • EVC $1.58
  • 52 Week High
  • OCGN $2.06
  • EVC $2.73
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 46.49
  • EVC 46.88
  • Support Level
  • OCGN $0.65
  • EVC $1.76
  • Resistance Level
  • OCGN $0.75
  • EVC $1.97
  • Average True Range (ATR)
  • OCGN 0.05
  • EVC 0.08
  • MACD
  • OCGN -0.01
  • EVC 0.01
  • Stochastic Oscillator
  • OCGN 15.38
  • EVC 50.00

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: